These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6701907)

  • 1. The toxicology of chemical interactions during pregnancy in the mouse: caffeine and phenytoin.
    Skalko RG; Poche PD; Kwasigroch TE
    Toxicology; 1984 Feb; 30(1):7-16. PubMed ID: 6701907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative teratogenicity of cortisone and phenytoin in mice.
    McDevitt JM; Gautieri RF; Mann DE
    J Pharm Sci; 1981 Jun; 70(6):631-4. PubMed ID: 7252805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiating effects of caffeine on teratogenicity of alkylating agents in mice.
    Fujii T; Nakatsuka T
    Teratology; 1983 Aug; 28(1):29-33. PubMed ID: 6415842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
    Wong M; Helston LM; Wells PG
    Teratology; 1989 Aug; 40(2):127-41. PubMed ID: 2772848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional investigation on the potentiation of phenytoin teratogenicity by fluconazole.
    Tiboni GM; Giampietro F; Angelucci S; Moio P; Bellati U; Di Ilio C
    Toxicol Lett; 2003 Dec; 145(3):219-29. PubMed ID: 14580893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of route of administration on phenytoin teratogenicity in A/J mice.
    Hansen DK; Billings RE
    J Craniofac Genet Dev Biol; 1986; 6(2):131-8. PubMed ID: 3722339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between caffeine and adenosine agonists in producing embryo resorptions and malformations in mice.
    Clark RL; Eschbach K; Cusick WA; Heyse JF
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):371-85. PubMed ID: 3424371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological and environmental determinants of phenytoin teratogenicity: relation to glutathione homeostasis, and potentiation by acetaminophen.
    Wells PG
    Prog Clin Biol Res; 1983; 135():367-71. PubMed ID: 6665011
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of the teratogenic potential of caffeine ingested in drinking-water.
    Collins TF; Welsh JJ; Black TN; Ruggles DI
    Food Chem Toxicol; 1983 Dec; 21(6):763-77. PubMed ID: 6686582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between embryotoxic and genotoxic effects of phenytoin in mice.
    Barcellona PS; Barale R; Campana A; Zucconi D; Rossi V; Caranti S
    Teratog Carcinog Mutagen; 1987; 7(2):159-68. PubMed ID: 2885938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate on phenytoin-induced embryopathy in mice.
    Wells PG; Vo HP
    Toxicol Appl Pharmacol; 1989 Mar; 97(3):398-405. PubMed ID: 2609339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryotoxicity of phenytoin in adrenalectomized CD-1 mice.
    Hansen DK; Branham WS; Sheehan DM; Holson RR
    Proc Soc Exp Biol Med; 1992 Apr; 199(4):501-8. PubMed ID: 1549630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
    Wells PG; Zubovits JT; Wong ST; Molinari LM; Ali S
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for Ras-dependent signal transduction in phenytoin teratogenicity.
    Winn LM; Wells PG
    Toxicol Appl Pharmacol; 2002 Nov; 184(3):144-52. PubMed ID: 12460742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
    Wong M; Wells PG
    J Pharmacol Exp Ther; 1989 Jul; 250(1):336-42. PubMed ID: 2746506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Teratogenic and embryotoxic effects of caffeine: facts and hypotheses].
    Burdan F
    Pol Merkur Lekarski; 2000 Oct; 9(52):726-8. PubMed ID: 11144068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration by BAL (2,3-dimercapto-1-propanol) and DMPS (sodium 2,3-dimercapto-1-propanesulfonic acid) of arsenite developmental toxicity in mice.
    Domingo JL; Bosque MA; Llobet JM; Corbella J
    Ecotoxicol Environ Saf; 1992 Jun; 23(3):274-81. PubMed ID: 1376232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of embryotoxicity in mouse embryos following in utero exposure to 2'-deoxycoformycin (pentostatin).
    Airhart MJ; Robbins CM; Knudsen TB; Church JK; Skalko RG
    Teratology; 1993 Jan; 47(1):17-27. PubMed ID: 8475454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the proximate teratogen of the mouse fetal alcohol syndrome. 1. Teratogenicity of ethanol and acetaldehyde.
    Blakley PM; Scott WJ
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):355-63. PubMed ID: 6364455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratogenicity and developmental toxicity of chlorpyrifos. Maternal exposure during organogenesis in mice.
    Tian Y; Ishikawa H; Yamaguchi T; Yamauchi T; Yokoyama K
    Reprod Toxicol; 2005; 20(2):267-70. PubMed ID: 15907662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.